SC to decide whether to treat interest on DoT dues as opex

The Supreme Court will decide whether the interest paid on overdues to the Department of Telecom (DoT) can be treated as operating expenditure by operators.

PTI | April 21, 2011



The Supreme Court will decide whether the interest paid on overdues to the Department of Telecom (DoT) can be treated as operating expenditure by operators.

A three-judge bench has admitted a petition filed by Vodafone Essar Gujarat and decided to adjudicate whether such interest could be treated as operating expenditure.

Earlier, the Income Tax Appellate Tribunal (ITAT) had held that the such interest would not be treated as a part of the opex.

The dispute is over the return filed for the financial year 1999-2000 by Fascel Ltd, now Vodafone Essar Gujarat Ltd.

In the return filed in December 1999, the company had declared a loss of Rs 86 crore.

IT officials found that Vodafone had claimed Rs 38.66 crore as expenditure for interest on its licence fee dues, as well as Rs 1.28 crore paid to Wireless Planning Commission in spectrum (radio waves) charges.

In 2002, the I-T department disallowed Vodafone's claim on interest and payment made to WPC under section 35 ABB and 43B of the Income Tax Act, 1961. It said the payments were not made during the relevant period.

Section 35ABB deals with the expenditure for obtaining licence to telecom operators.

It was challenged before the ITAT, which said in May, 2006 that the fee paid to WPC was part of the expenditure but the interest was not, as it was not covered under the section.

Vodafone moved the Delhi High Court which, in December 2008, affirmed the ITAT order on the WPC issue. Now, the company has moved the Supreme Court.
 

Comments

 

Other News

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Development paradox: Falling poverty miracle and an inequality problem

India’s reduction in poverty over the past decade is a development achievement of considerable significance. The World Bank’s April 2026 ‘India Development Update’ estimates that the share of Indians living below the international extreme-poverty line of $3.00 per person per day i

In Arunachal, a river we call mother

In Arunachal Pradesh, the Siang is not just a river. For many of us, especially the Adi people, it is part of our family. Our grandparents fished in it. Children learned to swim in it. Our farms drink from it. When someone says a huge dam will be built on it, we do not hear the word "project".

A new retelling of the Mahabharata delves into key moments

In a time when every decision carries consequences and questions of ambition, power, loyalty, identity and moral choice continue to shape our lives, Dr. Arun Krishnan’s new book, ‘Mahakshana’ (Penguin India) offers a strikingly relevant retelling of the Mahabharata.  

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter